Previous Article | Next Article 
Applied and Environmental Microbiology, September 1999, p. 4032-4039, Vol. 65, No. 9
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Development and Field Performance of a Broad-Spectrum Nonviable
Asporogenic Recombinant Strain of Bacillus thuringiensis
with Greater Potency and UV Resistance
Vincent
Sanchis,1,2,*
Michel
Gohar,3,
Josette
Chaufaux,2
Olivia
Arantes,1,
Alain
Meier,4
Hervé
Agaisse,1,2
Jane
Cayley,5 and
Didier
Lereclus1,2
Unité de Biochimie
Microbienne1 and Laboratoire des
Fermentations, Unité de Physiologie
Cellulaire,4 Institut Pasteur, Centre National
de la Recherche Scientifique, 75724 Paris Cedex 15, Station de
Recherches de Lutte Biologique, Institut National de la Recherche
Agronomique, La Minière, 78285 Guyancourt,2 and AgrEvo Prodetech,
13367 Marseille Cedex 11,3 France, and
Hoechst Schering AgrEvo GmbH, Hoechst Works, D-65926
Frankfurt am Main, Germany5
Received 4 March 1999/Accepted 8 July 1999
 |
ABSTRACT |
The main problems with Bacillus thuringiensis products
for pest control are their often narrow activity spectrum, high
sensitivity to UV degradation, and low cost effectiveness (high potency
required). We constructed a sporulation-deficient SigK
B. thuringiensis strain that expressed a chimeric
cry1C/Ab gene, the product of which had high activity
against various lepidopteran pests, including Spodoptera
littoralis (Egyptian cotton leaf worm) and Spodoptera
exigua (lesser [beet] armyworm), which are not readily
controlled by other Cry
-endotoxins. The SigK
host
strain carried the cry1Ac gene, the product of which is highly active against the larvae of the major pests Ostrinia
nubilalis (European corn borer) and Heliothis
virescens (tobacco budworm). This new strain had greater potency
and a broader activity spectrum than the parent strain. The crystals
produced by the asporogenic strain remained encapsulated within the
cells, which protected them from UV degradation. The
cry1C/Ab gene was introduced into the B. thuringiensis host via a site-specific recombination vector so
that unwanted DNA was eliminated. Therefore, the final construct contained no sequences of non-B. thuringiensis origin. As
the recombinant strain is a mutant blocked at late sporulation, it does
not produce viable spores and therefore cannot compete with wild-type
B. thuringiensis strains in the environment. It is thus a
very safe biopesticide. In field trials, this new recombinant strain
protected cabbage and broccoli against a pest complex under natural
infestation conditions.
 |
INTRODUCTION |
Every year, insect pests cause
between a 15 and 25% loss of agricultural production worldwide. Yield
losses vary widely between crops and geographic areas. Various
strategies have been used to reduce or control this agricultural
damage, the principal strategy being the use of chemical insecticides
(23). The application of these synthetic compounds has
resulted in the stabilizing or even increasing of agricultural yields.
However, this strategy has now become one of the most costly aspects of
agriculture. Moreover, the large-scale and indiscriminate use of
nonspecific products, often toxic to mammals, birds, and fish, has
resulted in contamination of the environment, destruction of nontarget organisms, and the development of pest resistance. Since the 1960s, biological pesticides have been seen as an environmentally benign, highly desirable alternative to chemicals and have therefore received considerable attention. Nevertheless, biopesticides have captured only
a scant 2% of the pesticide market and have not significantly reduced
chemical pesticide use (24).
The most widely used microbial pesticides worldwide are those based on
preparations of the bacterium Bacillus thuringiensis (16, 24). B. thuringiensis is a spore-forming
bacterium that produces highly specific insecticidal proteins, the
-endotoxins, during sporulation.
-Endotoxins accumulate as
crystalline inclusions within the cell. At the end of sporulation, the
cells lyse and the spores and crystals are liberated. If ingested by
susceptible insects (usually the larvae), the crystals are dissolved
and the
-endotoxins, which are protoxin molecules, are specifically
cleaved by insect gut proteases. The resulting activated toxins
recognize specific receptors on the surfaces of the midgut epithelium
cells and cause cell lysis and the death of insect larvae
(10). Most of the
-endotoxins are active against a small
number of insect species. Commercial B. thuringiensis
products generally consist of a mixture of spores and crystals,
produced in large fermenters and applied as foliar sprays, much like
synthetic insecticides.
Biopesticides containing B. thuringiensis are
environmentally friendly and effective in a variety of situations.
However, their performance is often considered to be poorer than that
of chemicals in terms of reliability, spectrum of activity, speed of
action, and cost effectiveness. B. thuringiensis products
are not as potent or persistent in the field as chemical products: B. thuringiensis products act slowly, have a narrow activity
spectrum (minimizing the size of their potential market), and are not
stable in the environment after spraying because they are rapidly
inactivated by exposure to sunlight (25) or other
environmental factors. Consequently, the duration of pest control is
often too short and its use on many crops is not cost-effective because
too many applications are required (8). Therefore, the
economic viability and acceptability of B. thuringiensis
biopesticides depends on the potency and spectrum of activity of the
insecticidal toxins in the crystals and the ability of these products
to control insect pests resistant to other insecticides, rather than on
their low ecotoxicity and other ecological advantages. The
environmental stability of the crystals after spraying is also
important as it determines the duration of pest control and the number
of applications needed.
We have shown that a recombinant B. thuringiensis strain
expressing an additional cry1 gene under the control of the
cry3A gene expression system (30) yields more
crystal protein than the wild-type strain. This is presumably because
the expression systems of the cry genes differ and,
therefore, do not compete for rate-limiting gene expression factors
(2). Thus, it may be possible to increase the total amount
of toxin produced in a B. thuringiensis strain. We have also
shown that as much Cry1Aa protein is produced by a wild-type
cry1Aa gene introduced by electroporation into a B. thuringiensis mutant, blocked at late sporulation by disruption of
the chromosomal sigK gene, as is produced by the Spo+ strain (7). The toxins accumulated in the
mother cell compartment to form crystal inclusions, which remained
encapsulated within the cell wall.
We report herein the construction and field trials of a new recombinant
B. thuringiensis strain that produces large amounts of two
different crystal proteins and show that encapsulation of the toxins
within the cell protects them from deactivation by UV radiation. The
strain is a sporulation-deficient mutant that cannot survive in the
environment, thereby minimizing any environmental effects arising from
the dissemination of large numbers of viable spores.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and media.
B.
thuringiensis strains and plasmids used in this work are listed in
Table 1. Escherichia coli
SCS110 [rpsL (Str) thr leu endA thi-1 lacY galK galT
ara tonA tsx dam dcm supE44
(lac-proAB) (F'
traD36 proAB lacIqZ
M15)] was used
as the host for plasmid construction. B. thuringiensis strains were grown at 30°C with shaking in Luria broth (LB) or hydrolysate of casein tryptone (HCT) medium (17). E. coli was grown at 37°C in LB. Antibiotic concentrations for
bacterial selection were as follows: ampicillin, 100 µg/ml
1 (for E. coli); erythromycin and
tetracycline, 10 µg/ml
1 (for B. thuringiensis); and kanamycin, 200 µg/ml
1 (for
B. thuringiensis).
For greenhouse and field trials, strains AGRO1 and AGRO2 were grown in
200 liters of HCT medium in a 300-liter Biolafitte fermenter
(Biolafitte, St. Germain-en-Laye, France) for 30 h. Biomass was
collected by centrifugation at 14,000 × g in a
Sharples AS16 centrifuge with a yield of 100 liters/h. The lysed AGRO2 spore-crystal biomass and AGRO1-cell-crystal biomass were washed once
with 20 liters of 0.15 M NaCl and once with 20 liters of distilled
water by centrifugation for 30 min at 14,000 × g in a
Sharples AS16 centrifuge, with a yield of 60 liters/h. The pellets were
freeze-dried. The yields were 1 g of freeze-dried powder per liter
for AGRO2 and 2 g of freeze-dried powder per liter for AGRO1.
These powders were used to prepare wettable powder (WP) spray
formulations consisting of 50% AGRO1 or AGRO2 (20% of which was the
active ingredient [crystal protein]), 2% wetting agent, 0.5%
silica, and 47.5% clay.
pHTF3-1C/Ab was constructed by replacing the 3.4-kb
BglII-EcoRI fragment of pHTF3-1C (which contains
the 3' end and downstream adjacent regions of the cry1C
gene) with the 2.3-kb BglII-EcoRI DNA fragment of
pHT81 (which contains the 3' end and downstream adjacent region of the
hybrid cry1C/Ab gene). The resulting plasmid consisted of
the hybrid cry1C/Ab gene under the control of the cry3A promoter in pHT315 (3). The construction of
pHTF3-1C/Ab-IRS-K and pHTF3-1C/Ab-IRS-T is described in Fig.
1.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Construction of plasmids pHTBS-F3-1C/Ab,
pHTF3-1C/Ab-IRS-K, and pHTF3-1C/Ab-IRS-T. pHTBS-F3-1C/Ab was
constructed as follows: the 2.3-kbp BglII-EcoRI
DNA fragment of pHT81, which contains the 3' end and downstream
adjacent regions of the cry1C/Ab chimeric gene, was purified
and ligated with the 9-kbp BglII-EcoRI fragment
of pHTBS-F3-1C. pHTF3-1C/Ab-IRS-K was obtained by ligating the
SphI-AlwNI and XhoI-AlwNI
fragments of pHT-IRS-BSK (each carrying an IRS of Tn4430) to
the 6.82-kbp DNA fragment of pHTBS-F3-1C/Ab that contains the origin of
the replication of pHT1030 (ori B. thuringiensis) and the
chimeric cry1C/Ab gene under the control of the promoter of
the cry3A gene (Pcry3A). pHTF3-1C/Ab-IRS-T was
constructed by a three-way ligation as follows: the 1.6-kbp
Ecl136II-EcoRI DNA fragment of pHTBS2
(28) harboring a tetracycline resistance marker was purified
and ligated with the SmaI-EcoRI and
EcoRI-EcoRI fragments of pHTF3-1C/Ab-IRS-K.
Restriction sites destroyed during the manipulation are indicated by
square brackets, and only restriction sites relevant to the
experimental design are shown. The various boxes representing genes or
IRSs are not drawn to scale. Bt, B. thuringiensis.
|
|
DNA manipulation and transformation.
Plasmid DNA for
transformation was extracted from E. coli SCS110 by the
standard alkaline lysis procedure and was further purified by using a
Qiagen plasmid kit according to the manufacturer's instructions
(Qiagen GmbH, Hilden, Germany). Restriction enzymes and T4 DNA ligase
were obtained from New England Biolabs (Beverly, Mass.), and DNA
fragments used in cloning experiments were purified from agarose gels
by using a Prep-A-Gene DNA purification matrix kit (Bio-Rad,
Laboratories, Richmond, Calif.).
E. coli SCS110 was transformed by electroporation. Plasmid
DNA was then isolated from this strain and used to electrotransform B. thuringiensis strains 407
, Kto, and its
derivatives, as previously described (18). Plasmid DNA was
extracted from B. thuringiensis by alkaline denaturation, and DNA was analyzed by electrophoresis in horizontal 0.8% agarose slab gels.
Irradiation of B. thuringiensis samples with a solar
simulator.
B. thuringiensis samples were irradiated with a
solar simulator (Suntest) from Heraeus, which delivered a spectrum
equivalent to that of sunlight passing through the earth's atmosphere.
The products (0.5 mg of toxins) were sprayed onto 7- by 7-cm glass plates and freeze-dried. The coated plates were irradiated for 1 h
by using the Suntest machine. The Suntest uses a xenon lamp emitting
from 280 to 800 nm at 100 klx (10 times the intensity of light reaching
the earth's surface in 1 h). During irradiation, the glass plates
were cooled at 10°C. The irradiated toxins were recovered and
bioassayed against Heliothis virescens as described below.
For each irradiated sample, a control sample from the same batch was
sprayed onto glass plates, freeze-dried, and recovered under the same
conditions as for the irradiated plates.
Bioassays of insecticidal activity.
The quantity of protein
in the preparations was estimated as follows. Sporulated and lysed
cultures or cell-crystal suspensions were washed twice with 0.15 M NaCl
and twice with distilled water. The protein concentration of the
spore-crystal preparation or cell-crystal suspension was then assayed
by using the Bio-Rad protein test. Ghost cells were briefly sonicated
to liberate the crystals before protein assays were performed.
(i) Laboratory bioassays.
Biological assays were conducted
by using free ingestion techniques and neonates, the first and second
instar larvae of several different insect species: Spodoptera
littoralis, Spodoptera frugiperda, H. virescens, Ostrinia nubilalis, and Plutella
xylostella. The activities against S. littoralis,
S. frugiperda, and O. nubilalis were determined
by contaminating an artificial diet dispensed into 50-well plates
(165-mm2 surface). Five concentrations of each preparation
were applied uniformly over the food surface in the wells. One second
(S. littoralis or S. frugiperda) or first
(O. nubilalis) instar larva was placed in each of the 50 wells. Each concentration was tested two to four times. Mortality was
scored after 5 days. H. virescens larvae were fed with an
artificial diet in plastic feeding cups (175-mm2 surface);
one neonate was placed in each cup, and mortality was scored after 7 days. Sixteen neonates were challenged with each of five dilutions of
the preparations (four independent experiments). Bioassays on P. xylostella were performed by surface contamination of cabbage leaf
disks with a calibrated sprayer that uniformly delivered a known amount
of toxin per square centimeter of leaf surface. Leaf disks (2.5-cm
diameter) were cut out, treated, and placed in individual cups (five
cups per dilution), and six second instar larvae were added to each
cup. Mortality was assessed after 5 days. Mortality data were analyzed
by using the log-probit program of Raymond et al. (26),
which tests for the linearity of dose-mortality curves and calculates
lethal concentrations and the slope of each curve. It also assesses
whether two or more dose-mortality curves are parallel, calculates the
ratios of different curves, and indicates whether the curves are
significantly different (P < 0.05). Lethal concentrations are expressed per square centimeter of artificial diet
or surface.
(ii) Greenhouse trials.
The efficacy of the recombinant
B. thuringiensis strains AGRO1 and AGRO2 against P. xylostella (diamondback moth) on cabbage was assessed in
greenhouse conditions and compared with that of the standard B. thuringiensis products Delfin WG and Thuricide HP and the chemical
insecticides Agrimek EC1.8, Decis EC2.5, and Hostathion EC40. The
treatments involved applying AGRO1 and AGRO2 WP formulations at 10, 20, 40, 80, and 160 g of active ingredient per ha (ai/ha); Delfin WG
at 125 to 1,000 g of ai/ha; Thuricide HP at 625 g of ai/ha;
Agrimek EC1.8 at 18 g of ai/ha; Decis EC2.5 at 7.8 g of
ai/ha; and Hostathion EC40 at 250 g of ai/ha to potted cabbage
plants with a boom sprayer at a rate of 500 liters/ha. Four replicates
per treatment were used in a complete randomized block design with a
plot size of one plant. The treatment was applied 1 day after
artificial infestation with 20 first and second instar larvae of
P. xylostella per cabbage plant. One, 3, and 7 days after
application, the numbers of dead and living larvae were counted on each
plant and the percentage of dead larvae was calculated. The percent
feeding damage by lepidopteran larvae was estimated, using Abbott's
formula, for total leaf (plant) surface and was calculated plotwise
(average of all treated plants for a given dose); treated plots were
compared with those of untreated controls.
(iii) Field trials.
The protection against natural
infestation provided by AGRO1 and AGRO2 was assessed on cabbage and
broccoli during the late cropping season of 1996 at the Western Field
Research Station of AgrEvo in Fresno, Calif. AGRO1 and AGRO2 WP
formulations at 20, 40, and 80 g of ai/ha and a control (the same
as the WP formulation but without the B. thuringiensis
extract) were applied to one broccoli and two cabbage plots. A
commercial B. thuringiensis product, Mattch 126 SC (588 g of
ai/ha), and the chemical insecticide Lannate 90 WP (1,121 g of ai/ha)
were used as standards. Each trial was replicated three times and
involved randomized blocks (plots) of 9.29 m2, with five
plants per plot and one plot per concentration. Two to four
applications were sprayed at intervals of 4 to 7 days (depending on the
trial) with a spray volume of 340 liters/ha. The total number of dead
and alive larvae per plot (five plants) was counted before each new
application and at the end of the study. The percent damage due to
insect feeding was assessed plotwise (average of all treated plants) by
determining total leaf (plant) surface before treatment and 9 days
after the last application; efficacy was calculated by using Abbott's formula.
 |
RESULTS |
Activity of a chimeric Cry1C/Ab toxin against several lepidopteran
insects.
We have reported the construction of a chimeric
-endotoxin gene, cry1C/Ab, in pHT81 (29)
(Table 1 and Fig. 1). This hybrid toxin gene comprised the 2,194 5'
nucleotides of the coding region of the cry1C gene and the
1,295 3' nucleotides of the coding region of the cry1Ab
gene, both from B. thuringiensis aizawai 7-29 (HD137) (28). The fusion was made by using the unique
KpnI site present in a region conserved between the two
-endotoxin genes. This conserved carboxy-terminal half of the
-endotoxin molecule (or protoxin segment) is not essential for
toxicity and is cleaved during activation in the midgut of host
lepidopteran larvae. Thus, the resulting protease-resistant active
amino-terminal fragment of the chimeric Cry1C/Ab toxin is that of
Cry1C. However, preliminary toxicity data indicated that the hybrid
Cry1C/Ab toxin was more toxic than the Cry1C toxin to S. littoralis. We therefore compared the activities of the Cry1C and
Cry1C/Ab toxins against various major agricultural pests. The
acrystalliferous B. thuringiensis strain 407
was transformed with pHTF3-1C and pHTF3-1C/Ab, similar constructs harboring the native cry1C and hybrid
cry1C/Ab genes, respectively (Table 1) (see Materials and
Methods for construction details). Transformants were selected
for resistance to erythromycin and grown in HCT sporulation medium for
48 to 72 h. The production of crystals was monitored by
phase-contrast microscopy. Both 407
(pHTF3-1C) and
407
(pHTF3-1C/Ab) produced large bipyramidal inclusions.
The insecticidal activities of chimeric Cry1C/Ab and native Cry1C
crystal preparations were determined against S. littoralis,
O. nubilalis, and P. xylostella (Table
2): Cry1C/Ab was 3, 4, and 35 times more
active than Cry1C, respectively. The 50% lethal concentrations
(LC50s) and slopes of the dose-mortality curves for each
toxin against the three insect species were compared by using the
log-probit program of Raymond et al. (26). In each case, the
difference in activity between the two toxins was significant
(P < 0.05). We therefore used the Cry1C/Ab toxin gene
to construct B. thuringiensis strains with better pest
control properties.
Construction of a site-specific recombinant plasmid harboring
cry1C/Ab.
Site-specific recombination vectors for
introducing cry genes into B. thuringiensis
strains have been developed (6, 30, 31), facilitating the
construction of B. thuringiensis recombinant strains free of
antibiotic resistance markers and other non-B. thuringiensis
DNA sequences. These vectors harbor two internal resolution sites
(IRSs) of the B. thuringiensis class II transposons, Tn4430 (20) and Tn5401 (5),
that flank the DNA sequences not native to B. thuringiensis.
In an appropriate host background (B. thuringiensis strains
containing Tn4430 or Tn5401), site-specific recombination between the duplicate IRSs, catalyzed by the TnpI recombinase of Tn4430 or Tn5401, eliminates the
intervening DNA (6, 30, 31). We used this type of vector to
introduce the cry1C/Ab gene into B. thuringiensis
under the control of the promoter of the cry3A
-endotoxin
gene of B. thuringiensis subspecies tenebrionis (Fig. 1). cry1
-endotoxin genes are transcribed from
specific sporulation promoters, whereas the cry3A gene is
transcribed from a promoter which resembles vegetative promoters
(1). This makes it possible to produce this toxin
(19) or other Cry1 toxins (30) at high levels in
sporulation-deficient or wild-type backgrounds. The first construct,
pHTF3-1C/Ab-IRS-K, consisted of the origin of the replication of
pHT1030 and the chimeric cry1C/Ab gene under the control of
the cry3A promoter between two identical IRSs in direct
orientation flanking E. coli pBluescript II KS(
) and
the aphA3 gene of Enterococcus faecalis. The DNA
native to B. thuringiensis was thus separated from all other
sequences by the IRSs (Fig. 1). pHTF3-1C/Ab-IRS-T, harboring the
tet gene from Bacillus cereus in place of the
kanamycin cassette in pHTF3-1C/Ab-IRS-K, was also constructed (Fig. 1)
to be used in a B. thuringiensis
sigK::kan background (see below).
Construction of recombinant B. thuringiensis strains.
B. thuringiensis strains were constructed from a wild-type
strain of B. thuringiensis serovar kurstaki,
strain Kto, initially isolated in France by Kurstak (15).
The Kto strain contains, on a 75-kb plasmid, a copy of transposon
Tn4430 and a cry1Ac gene, the product of which is
highly active against the larvae of two major insect pests: O. nubilalis (European corn borer) and H. virescens
(tobacco budworm). A nonsporulating derivative of strain Kto was
obtained by disrupting the chromosomal sigK gene, which encodes the
28 sporulation-specific sigma factor, by in
vivo homologous recombination with a disrupted copy of
sigK::kan, as described by Bravo et al. (7), using the integrative thermosensitive vector pAB2.
Briefly, pAB2 was used to transform B. thuringiensis Kto by
electroporation, and transformants were selected at a nonpermissive
temperature for the integration of the vector into the chromosome at
the sigK locus. A second recombination event was then
selected such that the vector was eliminated. The B. thuringiensis Kto SigK
mutant, unlike the wild-type
B. thuringiensis strain Kto, did not produce mature-phase
refractile spores at the end of sporulation. Instead, it produced large
parasporal inclusions (composed of Cry1Ac) that remained encapsulated
in the cells, which did not lyse. Under the light microscope,
SigK
cells grown to stationary phase looked like ghost
cells. The insecticidal activities of spore-crystal or cell-crystal
preparations of the Kto and Kto SigK
strains were
analyzed against H. virescens. The LC50s were
2.5 ng/cm2 for Kto and 12 ng/cm2 for Kto
SigK
. The lower activity of the Kto SigK
strain may have been due to the crystals being tightly encapsulated and
therefore less available to the insect. A second asporogenic recombinant strain (designated AGRO1) was constructed by introducing the cry1C/Ab gene, the product of which is active against
spodopteran pests such as S. littoralis (Egyptian cotton
leafworm) and Spodoptera exigua (lesser [beet]
armyworm), into the B. thuringiensis Kto SigK
background. pHTF3-1C/Ab-IRS-T, carrying the
cry1C/Ab toxin gene, was introduced into the B. thuringiensis Kto SigK
strain by electroporation,
and tetracycline-resistant colonies were selected on LB plates. The
tetracycline resistance gene and the E. coli DNA present on
pHTF3-1C/Ab-IRS-T were eliminated (to yield the recombined plasmid
pHTF3-1C/Ab-IRS-T-
) by growing the Tetr transformants in
nonselective medium as previously described (31). The
presence of pHTF3-1C/Ab-IRS-T-
in AGRO1 was confirmed by restriction
enzyme analysis (Fig. 2). A third
recombinant strain, AGRO2, consisting of the Kto strain expressing both
the cry1Ac and cry1C/Ab genes, was also
constructed. AGRO2 was morphologically indistinguishable from its
parental strain, differing only in the presence of the recombined
plasmid, pHTF3-1C/Ab-IRS-T-
, containing the cry1C/Ab gene
and the ori B. thuringiensis (Fig. 2). It was expected to
have the same activity spectrum as AGRO1 but to produce viable spores
that might germinate and multiply in favorable nutritional conditions,
such as those in the insect's gut. Its survival in the environment was
expected to be similar to that of a natural B. thuringiensis
strain.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 2.
Agarose gel electrophoresis of
BamHI-XhoI-EcoRI-digested plasmid DNA
from native and transformed B. thuringiensis Kto and Kto
SigK strains. Lanes: 1 and 8, 1-kb DNA ladder; 2, Kto
recipient; 3, Kto (pHTF3-1C/Ab-IRS-T- ); 4 and 7, pHTF3-1C/Ab-IRS-T
isolated from E. coli; 5, Kto SigK
(pHTF3-1C/Ab-IRS-T- ); 6, Kto SigK recipient. The
2.9-kbp BamHI DNA fragment corresponding to the pBluescript
II KS( ) and the 1.6-kbp BamHI-EcoRI DNA
fragment corresponding to the tet gene of B. cereus are indicated by black arrows (lane 7). These DNA fragments
are absent from the Kto and Kto SigK transformants
harboring pHTF3-1C/Ab-IRS-T- . Only the 2.6-kbp
EcoRI-XhoI and 4.3-kbp
BamHI-EcoRI DNA fragments corresponding to the
origin of replication of pHT1030 and the cry1C/Ab gene,
respectively, remain (indicated by open triangles in lanes 3 and 5)
after the site-specific recombination that removes the tet
gene and pBluescript II KS( ). The sizes (in kilobase pairs) of the
1-kb ladder are shown on the right.
|
|
Effects of crystal encapsulation on residual insecticidal activity
after UV irradiation.
Strains AGRO1 and AGRO2 produced identical
crystals. However, AGRO1 crystals remained encapsulated in the cells,
whereas those of AGRO2 were released. These strains and a natural
aizawai strain, the active ingredient of Xentari WDG
(Abbott), were used to determine whether encapsulation protects
-endotoxins from sunlight-mediated degradation. Spore-crystal
preparations of AGRO2, the reference aizawai strain, and
cell-crystal suspensions of AGRO1 were irradiated for 1 h under
controlled conditions (see Materials and Methods). The toxicities of
irradiated and control samples from the same batch were tested against
H. virescens larvae (Table 3).
LC50s were significantly higher after irradiation
(P < 0.005) for AGRO2 and the aizawai
reference preparation than for the nonirradiated samples, whereas the
LC50s for AGRO1 did not differ significantly (P > 0.5) before and after irradiation.
Insecticidal activity of strains AGRO1 and AGRO2. (i) Laboratory
bioassays.
The insecticidal activity of strains AGRO1 and AGRO2
was assayed on larvae of H. virescens, S. littoralis, S. frugiperda, P. xylostella,
and O. nubilalis (LC50s are listed in Table
4). The LC50s of the two
crystal preparations did not differ significantly (P < 0.05) for S. littoralis, S. frugiperda, and
P. xylostella. However, the LC50s for H. virescens and O. nubilalis were significantly higher
for AGRO1 cell-crystal preparations than for AGRO2 free spore-crystal
preparations. This effect on H. virescens and O. nubilalis may be due to the slower release and/or dissolution of
the encapsulated AGRO1 crystal proteins in the gut of these insects.
Alternatively, the higher toxicity of strain AGRO2 may be due to
synergy with infectious live spores (9). We therefore compared, in the laboratory, the insecticidal activity of the AGRO1
strain with that of a combination of AGRO1 and 104 spores
of an acrystalliferous derivative of strain Kto (Kto
)
(31) against O. nubilalis and P. xylostella. Two independent experiments indicated that, for
O. nubilalis, the LC50 of the combined
spore-crystal preparation was significantly lower (P < 0.05) than that of AGRO1 {LC50s of 4 (95%
confidence interval [CI], 3 to 5) ng/cm2 and 20 (95% CI,
17 to 26) ng/cm2, respectively}, indicating that spores
increased the toxicity of AGRO1 crystals to the European corn borer. In
contrast, for P. xylostella (three experiments), the
difference in activity between the two preparations was not significant
(P > 0.05) (LC50s of 1.5 [95% CI, 0.9 to
2.1] ng/cm2 and 2.4 [95% CI, 0.6 to 8.7]
ng/cm2, respectively).
(ii) Greenhouse trials.
AGRO1 and AGRO2 preparations were
tested against P. xylostella (diamondback moth) on cabbage
in greenhouse conditions (Table 5). At
the standard application rates of 40 and 80 g of ai/ha, both
strains caused 97 to 100% larval mortality 7 days after application, with no significant difference between the two preparations. The minimum dose providing acceptable control of the pest (prevention of
feeding damage) was around 20 g of ai/ha for both. The two recombinant strains controlled the diamondback moth larvae infesting the cabbage with an efficacy matching or exceeding that of the chemical
standards and B. thuringiensis products tested (Table 5).
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Effects of B. thuringiensis AGRO1 and AGRO2 on
the mortality of P. xylostella larvae and on the damage
inflicted on cabbage, compared with the effects of other B. thuringiensis and chemical
insecticidal productsa
|
|
(iii) Field trials.
Field trials were conducted with cabbage
and broccoli to assess the value of AGRO1 and AGRO2 in field conditions
against various lepidopteran pests in natural infestation conditions.
The AGRO1 and AGRO2 preparations, the commercial B. thuringiensis product Mattch 126 SC, and the chemical insecticide
Lannate 90 WP were applied by spraying two to four times, and the
damage to cabbage and broccoli was assessed 9 days after the last
application (Table 6). AGRO1 and AGRO2
treatments significantly and dose dependently reduced insect damage.
Untreated larvae of a natural pest complex consisting of
Trichoplusia ni, Artogeia rapae, and P. xylostella caused 37, 48, and 67% damage, respectively, in three
independent trials, whereas losses in AGRO1- or AGRO2-treated plots at
the maximum dose of 80 g of ai/ha were 7, 18, and 27% (AGRO1),
respectively, or 6, 15, and 27% (AGRO2), respectively. Both strains
applied at 80 g of ai/ha were as effective as the reference
materials Mattch (588 g of ai/ha) and Lannate (1,121 g of ai/ha)
against the cabbage pest complex.
View this table:
[in this window]
[in a new window]
|
TABLE 6.
Field performances of B. thuringiensis AGRO1
and AGRO2 against a natural infestation of worms on cabbage
and broccolia
|
|
 |
DISCUSSION |
We report the construction of two new recombinant B. thuringiensis strains, AGRO1 and AGRO2, their use to test the
effect of encapsulation on crystal toxicity, and their residual
activity after UV exposure. Sunlight-mediated inactivation of B. thuringiensis crystals is often cited as the major factor
affecting the performance and economic viability of B. thuringiensis products. Irradiation destroys up to 35% of
tryptophan residues in purified B. thuringiensis subspecies
HD1 and HD73 crystals, resulting in a loss of toxicity (25).
Encapsulated crystals produced by AGRO1 were better protected against
UV than unencapsulated crystals produced by AGRO2 or by the natural
aizawai strain that constitutes the active ingredient of
Xentari (Table 3). Therefore, formulations in which mature crystals are
produced and encapsulated in B. thuringiensis ghost cells
show promise for reducing the loss of biological activity due to
sunlight in the field. We also show increased activity of the Cry1C
toxin against certain insect pests by replacing part of its
carboxy-terminal protoxin region with the equivalent region from the
Cry1Ab
-endotoxin (Table 2). This increase in toxicity was
presumably due to the fusion protein containing a portion of the
carboxy-terminal half of Cry1Ab, which lacks 26 amino acids, including
four cysteine residues likely to be involved in the formation of the
protease-resistant crystal structure via disulfide bond formation. This
may increase the solubility of the chimeric protein relative to that of
native Cry1C, accounting for differences in toxicity between the
crystals. Toxicity requires the
-endotoxins to be solubilized and
activated in the gut of insect larvae. Hence, the efficacy of a
particular
-endotoxin is partly dependent on its solubility and
proteolytic cleavage into toxins. This has been shown for the crystal
produced by B. thuringiensis subsp. aizawai
(HD133) (4). We assessed the efficacy of encapsulated and
nonencapsulated chimeric crystal proteins in field trials. Both AGRO1
and AGRO2 strains effectively controlled various lepidopteran pests on
cabbage in artificial and natural infestation conditions (Tables 4 to
6). AGRO2 was slightly more biologically active than AGRO1 in
laboratory bioassays (Table 4); this difference in activity was
significant (P < 0.05) for H. virescens and
O. nubilalis but not for S. littoralis, S. frugiperda, and P. xylostella (P > 0.05). The addition of spores to the AGRO1 preparation did not
change its activity against P. xylostella but reduced its LC50 against O. nubilalis by a factor of 5. This
is consistent with the difference in activity between AGRO1 and AGRO2
toward O. nubilalis (Table 4). It suggests that the lower
potency of AGRO1 than AGRO2, in laboratory bioassays, against O. nubilalis reflects the contribution of spores to toxicity in this
insect species rather than encapsulated crystals being less available to insects. The spores of B. thuringiensis subsp.
kurstaki HD1 have been described as having a similar effect
against Plodia interpunctella (Indian meal moth) larvae. In
this species, spore germination and the resulting septicemia in larval
hemolymph synergized the toxicity of purified Cry1Ab and Cry1C crystal
proteins (13, 14). In greenhouse and field conditions, the
efficacy of AGRO1 and AGRO2 strains, applied at 80 g of ai/ha, for
the control of lepidopteran pests was equivalent to that of the
reference products Mattch and Lannate (Tables 5 and 6). However, these
trials involved comparing nonoptimized formulations of AGRO1 and AGRO2
with commercial formulations of chemical and other B. thuringiensis products. The efficacy of these new recombinant
strains could still be greatly increased by formulation.
Another important feature of the AGRO1 recombinant strain is that it is
a mutant blocked at late sporulation that does not produce viable
spores. Sporogenic B. thuringiensis strains have been used
for more than 40 years and have a good safety record for vertebrates
and other nontarget organisms. However, in rare cases, B. thuringiensis has been shown to be responsible for infections in
man (11, 27). A case of severe war wounds becoming infected by B. thuringiensis serotype H34 has been described, and
this strain was found to be pathogenic in a mouse model of cutaneous infection (12). B. thuringiensis spores also
frequently infect larvae of the mulberry silkworm, Bombyx
mori, in silkworm-rearing areas (21), and a recent
study has also reported adverse effects of a B. thuringiensis formulation on a beneficial organism commonly used
to control lepidopteran pests (22). Biological safety and environmental impact are therefore important considerations, of increasing public concern, that must be taken into account when developing new genetically engineered biopesticides. The recombinant AGRO1 strain is asporogenic and is therefore at a considerable competitive disadvantage compared to wild-type B. thuringiensis strains present in the environment and sporogenic
commercial and recombinant B. thuringiensis strains. We
found that a culture of AGRO1 grown for 30 h at 30°C in liquid
HCT medium and plated onto nutrient agar plates gave no colonies (data
not shown), indicating that at this stage (after the
sporulation-deficient cells have produced crystal inclusions) the cells
are no longer viable. Consequently, the ecological impact of
disseminating AGRO1 or other asporogenic B. thuringiensis
strains should be extremely low, as their viability is much lower than
that of natural strains.
Toxin encapsulation with asporogenic strains, therefore, has two
potential advantages: (i) improved biological and environmental safety
(the strains are nonviable and do not contain foreign DNA
except the
kan cassette in the chromosome, but this gene can be
removed
minimizing the risks of accidental infection and DNA transfer
and dissemination) and (ii) UV light resistance (the
-endotoxins are
better protected from degradation than the nonencapsulated
-endotoxins). A possible disadvantage is the absence of spores that
sinergistically increase toxicity for certain insects. However, in
greenhouse and field tests, the potency and efficacy of the
encapsulated asporogenic strain were similar to those of the B. thuringiensis-based and synthetic insecticides tested. Therefore,
this mutant could be used to design and construct a new generation of
recombinant B. thuringiensis strains that are more
environmentally friendly than the existing sporogenic commercial
strains. In addition, costs associated with the
irradiation of
B. thuringiensis formulations to kill the spores before sale
(when required) and with adding UV protectants to B. thuringiensis products (to avoid the rapid loss of their
biological activity after spraying) are avoided with asporogenic mutants.
 |
ACKNOWLEDGMENTS |
We are grateful to Georges Rapoport, in whose laboratory this
work was conducted. We thank Ronald Wilhelm for supervising the
greenhouse and field trials, David Lobo and Arnold Estrada for
conducting the greenhouse trials, and Arlene Kurokawa for conducting
the field trials. We also acknowledge Christine Dugast for typing the
manuscript and Julie Knight for revising the English text.
This work was supported by research funds from the Institut Pasteur,
Centre National de la Recherche Scientifique (CNRS), and the Institut
National de la Recherche Agronomique (INRA).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité de
Biochimie Microbienne, Institut Pasteur, 25-28, rue du Docteur Roux,
75724 Paris Cedex 15, France. Phone: 33 1 45 68 88 12. Fax: 33 1 45 68 89 38. E-mail: vsanchis{at}pasteur.fr.
Present address: Station de Recherches de Lutte Biologique, INRA,
La Minière, 78285 Guyancourt, France.
Present address: Departamento de Biologia Geral, Centro de
Ciencias Biologicas, Universidade Estadual de Londrina, Campus Universitario, 86051-970 Londrina, Pr., Brasil.
 |
REFERENCES |
| 1.
|
Agaisse, H., and D. Lereclus.
1994.
Expression in Bacillus subtilis of the Bacillus thuringiensis cryIIIA toxin gene is not dependent on a sporulation-specific sigma factor and is increased in a spo0A mutant.
J. Bacteriol.
176:4734-4741[Abstract/Free Full Text].
|
| 2.
|
Agaisse, H., and D. Lereclus.
1995.
How does Bacillus thuringiensis produce so much insecticidal crystal protein.
J. Bacteriol.
177:6027-6032[Free Full Text].
|
| 3.
|
Arantes, O., and D. Lereclus.
1992.
Construction of cloning vectors for Bacillus thuringiensis.
Gene
108:115-119.
|
| 4.
|
Aronson, A.
1995.
The protoxin composition of Bacillus thuringiensis insecticidal inclusions affects solubility and toxicity.
Appl. Environ. Microbiol.
61:4057-4060[Abstract].
|
| 5.
|
Baum, J. A.
1994.
Tn5401, a new class II transposable element from Bacillus thuringiensis.
J. Bacteriol.
176:2835-2845[Abstract/Free Full Text].
|
| 6.
|
Baum, J. A.,
M. Kakefuda, and C. Gawron-Burke.
1996.
Engineering Bacillus thuringiensis bioinsecticides with an indigenous site-specific recombination system.
Appl. Environ. Microbiol.
62:4367-4373[Abstract].
|
| 7.
|
Bravo, A.,
H. Agaisse,
S. Salamitou, and D. Lereclus.
1996.
Analysis of cry1Aa expression in sigE and sigK mutants of Bacillus thuringiensis.
Mol. Gen. Genet.
250:734-741[Medline].
|
| 8.
|
Cannon, R. J. C.
1995.
Bacillus thuringiensis in pest control, p. 190-200.
In
H. M. T. Hokkanen, and T. M. Lynch (ed.), Biological control: benefits and risks. Cambridge University Press, Cambridge, England.
|
| 9.
|
Dubois, N. R., and D. H. Dean.
1995.
Synergism between Cry1A insecticidal crystal proteins and spores of Bacillus thuringiensis, other bacterial spores, and vegetative cells against Lymantria dispar (Lepidoptera: lymantriidae) larvae.
Environ. Entomol.
24:1741-1747.
|
| 10.
|
Entwistle, P. F.,
J. S. Corey,
M. T. Bayley, and S. Higgs (ed.).
1993.
Bacillus thuringiensis, an environmental biopesticide: theory and practice.
John Wiley and Sons Ltd., Chichester, England.
|
| 11.
|
Green, M.,
M. Heumann,
R. Sokolov,
L. R. Foster,
R. Bryant, and M. Skeels.
1990.
Public health implications of the microbial pesticide Bacillus thuringiensis: an epidemiological study, Oregon, 1985-1986.
Am. J. Public Health
80:848-852[Abstract/Free Full Text].
|
| 12.
|
Hernandez, E.,
F. Ramisse,
J. P. Ducoureau,
T. Cruel, and J. D. Cavallo.
1998.
Bacillus thuringiensis subsp. konkukian (serotype H34) superinfection: case report and experimental evidence of pathogenicity in immunosuppressed mice.
J. Clin. Microbiol.
36:2138-2139[Abstract/Free Full Text].
|
| 13.
|
Johnson, D. E., and W. H. McGaughey.
1996.
Contribution of Bacillus thuringiensis spores to toxicity of purified Cry proteins towards Indianmeal moth larvae.
Curr. Microbiol.
31:54-59.
|
| 14.
|
Johnson, D. E.,
B. Oppert, and W. H. McGaughey.
1998.
Spore coat synergizes Bacillus thuringiensis crystal toxicity for Indianmeal moth.
Curr. Microbiol.
36:278-282[Medline].
|
| 15.
|
Kurstak, E. S.
1962.
Données sur l'épizootie bactérienne naturelle provoquée par un Bacillus du type Bacillus thuringiensis sur Ephestia kuhniella Zeller.
Entomophaga Mem. Hors Ser.
2:245-247.
|
| 16.
|
Lambert, B., and M. Peferoen.
1992.
Insecticidal promise of Bacillus thuringiensis. Facts and mysteries about a successful biopesticide.
Bioscience
42:112-122.
|
| 17.
|
Lecadet, M.-M.,
M. O. Blondel, and J. Ribier.
1980.
Generalized transduction in Bacillus thuringiensis var. berliner 1715 using bacteriophage CP54-Ber.
J. Gen. Microbiol.
121:203-212[Medline].
|
| 18.
|
Lereclus, D.,
O. Arantes,
J. Chaufaux, and M.-M. Lecadet.
1989.
Transformation and expression of a cloned -endotoxin gene in Bacillus thuringiensis.
FEMS Microbiol. Lett.
60:211-218.
|
| 19.
|
Lereclus, D.,
H. Agaisse,
M. Gominet, and J. Chaufaux.
1995.
Overproduction of encapsulated insecticidal crystal proteins in a Bacillus thuringiensis spo0A mutant.
Bio/Technology
13:67-71[Medline].
|
| 20.
|
Mahillon, J., and D. Lereclus.
1988.
Structural and functional analysis of Tn4430: identification of an integrase-like protein involved in the co-integrate-resolution process.
EMBO J.
7:1515-1526[Medline].
|
| 21.
|
Mohan, K. S.,
R. Asokan, and C. Gopalakrishnan.
1997.
Development and field performance of a sporeless mutant of Bacillus thuringiensis subsp. kurstaki.
J. Plant Biochem. Biotechnol.
6:105-109.
|
| 22.
|
Nascimiento, M. L.,
D. F. Capalbo,
G. J. Moraes,
E. A. De Nardo,
A. H. N. Maia, and R. C. A. L. Oliveira.
1998.
Effect of a formulation of Bacillus thuringiensis berliner var. kurstaki on Podisus nigrispinus Dallas (Heteroptera: pentatomidae: asopinae).
J. Invertebr. Pathol.
72:178-180[Medline].
|
| 23.
|
Pimentel, D.
1991.
CRC handbook of pest management in agriculture, 2nd ed., vol. 1.
CRC Press, Boca Raton, Fla.
|
| 24.
|
Powell, K. A.
1993.
The commercial exploitation of microorganisms in agriculture, p. 441-459.
In
D. G. Jones (ed.), Exploitation of microorganisms. Chapman and Hall, London, England.
|
| 25.
|
Pusztai, M.,
M. Fast,
L. Gringorten,
H. Kaplan,
T. Lessard, and P. Carey.
1991.
The mechanism of sunlight-mediated inactivation of Bacillus thuringiensis crystals.
Biochem. J.
273:43-47.
|
| 26.
|
Raymond, M.,
G. Prato, and D. Ratsira.
1993.
Probit analysis of mortality assays displaying quantal response. Version 3.3. Praxème Sarl
St. Georges d'Orques, France.
|
| 27.
|
Samples, J. R., and H. Buettner.
1983.
Corneal ulcer caused by a biological insecticide (Bacillus thuringiensis).
Am. J. Ophthalmol.
95:258-260[Medline].
|
| 28.
|
Sanchis, V.,
D. Lereclus,
G. Menou,
J. Chaufaux, and M.-M. Lecadet.
1988.
Multiplicity of -endotoxin genes with different insecticidal specificities in Bacillus thuringiensis aizawai 7-29.
Mol. Microbiol.
2:393-404[Medline].
|
| 29.
|
Sanchis, V.,
D. Lereclus,
G. Menou,
J. Chaufaux,
S. Guo, and M.-M. Lecadet.
1989.
Nucleotide sequence and analysis of the N-terminal coding region of the Spodoptera-active -endotoxin gene of Bacillus thuringiensis aizawai 7-29.
Mol. Microbiol.
3:229-238[Medline].
|
| 30.
|
Sanchis, V.,
H. Agaisse,
J. Chaufaux, and D. Lereclus.
1996.
Construction of new insecticidal Bacillus thuringiensis recombinant strains by using the sporulation non-dependent expression systems of cryIIIA and a site-specific recombination vector.
J. Biotechnol.
48:81-96[Medline].
|
| 31.
|
Sanchis, V.,
H. Agaisse,
J. Chaufaux, and D. Lereclus.
1997.
A recombinase-mediated system for elimination of antibiotic resistance gene markers from genetically engineered Bacillus thuringiensis strains.
Appl. Environ. Microbiol.
63:779-784[Abstract].
|
Applied and Environmental Microbiology, September 1999, p. 4032-4039, Vol. 65, No. 9
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.